
Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study
Ahmedabad: Azmarda, an innovator brand of Sacubitril/Valsartan, demonstrated superior efficacy compared to generic Sacubitril/Valsartan in patients with heart failure with reduced ejection fraction (HFrEF), as assessed using global longitudinal …